geneCORE Somatic 52 Gene Panel

geneCORE 52 gene panel analyzes 52 genes associated with various types of cancer using next-generation sequencing (NGS) technology. The panel provides information on specific genetic alterations, including mutations, fusions, and copy number variations, which can guide therapy selection. By identifying actionable genetic changes, the test helps determine personalized treatment options such as targeted therapies or clinical trial eligibility. The Oncomine 52 gene panel with therapy selection enables precision medicine approaches, optimizing treatment strategies for cancer patients based on their unique genetic profiles.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.